Celcuity, Inc. (CELC)
107.51
+2.84
(+2.71%)
USD |
NASDAQ |
Jan 09, 16:00
103.51
-4.00
(-3.72%)
After-Hours: 20:00
Celcuity Research and Development Expense (Annual): 104.20M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Olema Pharmaceuticals, Inc. | 124.52M |
| Replimune Group, Inc. | 191.22M |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |
| Cidara Therapeutics, Inc. | 71.88M |
| Cogent Biosciences, Inc. | 228.26M |